Hubert Walinski
Directeur/Membre du Conseil chez CIPHER PHARMACEUTICALS INC.
Fortune : - $ au 30/04/2024
Profil
Hubert Walinski is currently an Independent Director at Cipher Pharmaceuticals, Inc. and the Chief Scientific Officer at Aic Global Holdings, Inc. Previously, he worked as the Head-Medical Respiratory, Immunology & Vaccines at AstraZeneca Canada, Inc. Mr. Walinski holds a doctorate degree from the University of British Columbia, which he obtained in 2007.
He also has an undergraduate degree from McMaster University, which he received in 2001.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Hubert Walinski
| Sociétés | Poste | Début |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 21/06/2023 |
| Aic Global Holdings, Inc. | Directeur Technique/Scientifique/R&D | 01/08/2021 |
Anciens postes connus de Hubert Walinski
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Directeur Technique/Scientifique/R&D | 01/07/2021 |
Formation de Hubert Walinski
| University of British Columbia | Doctorate Degree |
| McMaster University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Aic Global Holdings, Inc. | |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
